Stockscreener 앱 받기
4.31
4.36%
0.18
Corvus Pharmaceuticals Inc 주식(CRVS)의 최신 뉴스
Is Corvus Pharmaceuticals Inc. stock ready for a breakoutTrend Analysis for Safer Market Entries - Newser
Long term hold vs stop loss in Corvus Pharmaceuticals Inc.Strategy Builder for Growth Focused Traders - Newser
What makes Corvus Pharmaceuticals Inc. stock price move sharplyShort Term Momentum Based Trading Strategy - Newser
Is Now a Good Time to Reenter Corvus Pharmaceuticals Inc.Scalable Portfolio Growth Suggestions Released - beatles.ru
Corvus (CRVS) Q2 Loss Beats Estimates - AOL.com
Advanced analytics toolkit walkthrough for Corvus Pharmaceuticals Inc.Pattern Breakout Prediction for Short Term - Newser
How to forecast Corvus Pharmaceuticals Inc. trends using time seriesFree Entry Zone Strategy for Consistent Profit - Newser
Real time pattern detection on Corvus Pharmaceuticals Inc. stockTechnical Insight Guide for Safer Trades - Newser
What to expect from Corvus Pharmaceuticals Inc. in the next 30 daysFree Short Term Buy List With Stop Protection - Newser
Corvus plans Phase II trial for soquelitinib in atopic dermatitis, targeting 200 patients with 12-week treatment window - MSN
Traders Watching For Reversal Pattern in Corvus Pharmaceuticals Inc.AI Trading Suggestions With Accuracy Focus Released - metal.it
Can volume confirm reversal in Corvus Pharmaceuticals Inc.2-Day Signal Watch with Forecast Outcome - Newser
Sentiment analysis tools applied to Corvus Pharmaceuticals Inc.Free Trend Analysis for Safer Trades - Newser
Custom strategy builders for tracking Corvus Pharmaceuticals Inc.Free Pattern Detection for Entry Confirmation - Newser
Price action breakdown for Corvus Pharmaceuticals Inc.Predictive Screener for Daily Trade Watch - Newser
What recovery options are there for Corvus Pharmaceuticals Inc.Real Chart Based Opportunity Identification - Newser
Momentum divergence signals in Corvus Pharmaceuticals Inc. chartTechnical Trade Plan with Entry Checklist - Newser
Transcript : Corvus Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Is it time to cut losses on Corvus Pharmaceuticals Inc.Free Stock Screener With Smart Filters - Newser
Can technical indicators confirm Corvus Pharmaceuticals Inc.’s reversalFree Short Term Setup With Predictive Chart - Newser
Earnings call transcript: Corvus Pharmaceuticals’ Q2 2025 results show EPS beat By Investing.com - Investing.com South Africa
Earnings call transcript: Corvus Pharmaceuticals’ Q2 2025 results show EPS beat - Investing.com
Corvus Pharmaceuticals Inc (CRVS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada
Published on: 2025-08-08 00:04:14 - Newser
Corvus Pharmaceuticals Reports Q2 2025 Progress and Financials - TipRanks
Corvus Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Institutional scanner results for Corvus Pharmaceuticals Inc.Free Reliable Alerts for Daily Stock Movers - Newser
Corvus: Q2 Earnings Snapshot - San Francisco Chronicle
Corvus Reports Breakthrough: New Atopic Dermatitis Drug Shows Powerful 65% Disease Reduction in Phase 1 Trial - Stock Titan
Does Corvus Pharmaceuticals Inc. qualify in momentum factor screeningTrade Setup Builder with Custom Alerts - Newser
Why Corvus Pharmaceuticals Inc. stock attracts strong analyst attentionVolume Based Swing Signal Prediction Map - Newser
New Product Launches: Will They Boost Corvus Pharmaceuticals Inc. Stock in 2025Volume Spike Detection for Early Breakouts - Newser
Can swing trading help recover from Corvus Pharmaceuticals Inc. lossesLong Term Stock Growth Plan Suggestions - Newser
Corvus Pharmaceuticals Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Corvus Pharmaceuticals Ownership: Retail Investors Dominate with 48% Stake, Institutions Hold 33% - AInvest
Corvus Pharmaceuticals Inc. Breaks Losing Streak — Is the Trend ReversingPortfolio Diversification Stock Ideas From Experts - beatles.ru
How Corvus Pharmaceuticals Inc. stock performs during market volatilityFree Safe Entry Stock Watch Suggestions - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):